Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00428220
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:15.337792+00:00
Published At
2015-11-06T00:00:00+00:00
Record Updated At
2019-06-27
Results Posted At
2015-11-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Breast Cancer", "Advanced Breast Cancer", "Metastatic Castration Resistant Prostate Cancer", "Metastatic Renal Cell Cancer", "Non-Small Cell Lung Cancer", "Thyroid Cancer", "Advanced/Metastatic Non-Small Cell Lung Cancer", "Advanced Gastric Cancer", "Gastrointestinal Stromal Tumor", "Hepatocellular Carcinoma", "Pancreatic Islet Cell Carcinoma", "Pancreatic Neuroendocrine Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-06-27"
protocolSection.identificationModule.nctId
"NCT00428220"
protocolSection.identificationModule.officialTitle
"An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-11-06"

Study condition terms

  • Metastatic Breast Cancer (protocolSection.conditionsModule.conditions)
  • Advanced Breast Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Castration Resistant Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Advanced/Metastatic Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Advanced Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
  • Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Islet Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.